Loading…

Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives

Discrimination between the physiological cleavage fragments of fibrinogen and fibrin offers an approach to differentiation between fibrinogenolytic processes and fibrinolysis after coagulation. By use of the cleavage-associated neoantigen of fibrinogen (fg-Dneo) as a molecular marker, characteristic...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1973-04, Vol.70 (4), p.1169-1173
Main Authors: Plow, Edward F., Edgington, Thomas S.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c456t-e4072c1313faee23a412799905f8599335e8574ff461f2007c68c52706cc61233
cites
container_end_page 1173
container_issue 4
container_start_page 1169
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 70
creator Plow, Edward F.
Edgington, Thomas S.
description Discrimination between the physiological cleavage fragments of fibrinogen and fibrin offers an approach to differentiation between fibrinogenolytic processes and fibrinolysis after coagulation. By use of the cleavage-associated neoantigen of fibrinogen (fg-Dneo) as a molecular marker, characteristic differences between the D regions of fibrinogen derivatives and fibrin derivatives can be demonstrated. The expression of fg-Dneoby X, Y, D:E complex, and D-fragments of fibrinogen or fibrin is shown to be quantitative and unitary. Characteristic differences between fg-Dneosites present on fibrinogen cleavage fragments, as contrasted to fibrin cleavage fragments, are indicated by different competitive inhibition slopes, and appear to reflect differential binding affinity of selected anti-fg-Dneoantibodies for the specific molecular site. There is a linear relationship between the slope of quantitative competitive inhibition and the relative molar ratio of fibrinogen and fibrin derivatives. Identical immunochemical expressions are observed in vitro and in vivo, and support the thesis that cleavage in vivo is produced by plasmin. The differential immunochemical features of fg-Dneoexpression may be the result of stable conformational and/or subtle structural differences between the D region of fibrinogen and fibrin cleavage fragments and suggest that precise changes in the D region are associated with the fibrin transition. These molecular features not only provide additional insight into the molecular immunology and structure of fibrinogen, but also appear to offer a new molecular approach to discrimination between fibrinogenolytic mechanisms as contrasted to fibrinolysis secondary to coagulation.
doi_str_mv 10.1073/pnas.70.4.1169
format article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1073_pnas_70_4_1169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>62448</jstor_id><sourcerecordid>62448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-e4072c1313faee23a412799905f8599335e8574ff461f2007c68c52706cc61233</originalsourceid><addsrcrecordid>eNp9kc1vEzEQxS0EKqFw5YCEtKfedjtef60PHFBDAakCIcHZctxxcLXxBttJ6X-Po4QovfRkWe_3xs_zCHlLoaOg2OU62twp6HhHqdTPyIyCpq3kGp6TGUCv2oH3_CV5lfMdAGgxwBk547RnmtEZ-TEP2aWwCtGWEJfNN5xsLGGJMbhmHrzHhNFhbhZY7hFjcx0WKcSpAo2Nt4drM8cUtnXCFvNr8sLbMeObw3lOfl1_-nn1pb35_vnr1ceb1nEhS4scVO8oo8xbxJ7ZGklprUH4QWjNmMBBKO49l9T3AMrJwYlegXRO1vTsnHzYz11vFiu8dRhLsqNZ18_Y9GAmG8xjJYbfZjltDWeMC6j-i4M_TX82mItZ1VXgONqI0yabgWopBqUq2O1Bl6acE_rjGxTMrgOz68AoMNzsOqiG96fJjvhh6Sf6zvdfPfVfPKUbvxnHgn9LBd_twbtcpnQkZc_5wP4BE8Cj2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81965877</pqid></control><display><type>article</type><title>Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives</title><source>PubMed Central</source><source>JSTOR</source><creator>Plow, Edward F. ; Edgington, Thomas S.</creator><creatorcontrib>Plow, Edward F. ; Edgington, Thomas S.</creatorcontrib><description>Discrimination between the physiological cleavage fragments of fibrinogen and fibrin offers an approach to differentiation between fibrinogenolytic processes and fibrinolysis after coagulation. By use of the cleavage-associated neoantigen of fibrinogen (fg-Dneo) as a molecular marker, characteristic differences between the D regions of fibrinogen derivatives and fibrin derivatives can be demonstrated. The expression of fg-Dneoby X, Y, D:E complex, and D-fragments of fibrinogen or fibrin is shown to be quantitative and unitary. Characteristic differences between fg-Dneosites present on fibrinogen cleavage fragments, as contrasted to fibrin cleavage fragments, are indicated by different competitive inhibition slopes, and appear to reflect differential binding affinity of selected anti-fg-Dneoantibodies for the specific molecular site. There is a linear relationship between the slope of quantitative competitive inhibition and the relative molar ratio of fibrinogen and fibrin derivatives. Identical immunochemical expressions are observed in vitro and in vivo, and support the thesis that cleavage in vivo is produced by plasmin. The differential immunochemical features of fg-Dneoexpression may be the result of stable conformational and/or subtle structural differences between the D region of fibrinogen and fibrin cleavage fragments and suggest that precise changes in the D region are associated with the fibrin transition. These molecular features not only provide additional insight into the molecular immunology and structure of fibrinogen, but also appear to offer a new molecular approach to discrimination between fibrinogenolytic mechanisms as contrasted to fibrinolysis secondary to coagulation.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.70.4.1169</identifier><identifier>PMID: 4123931</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Abruptio Placentae - blood ; Acute Kidney Injury - blood ; Adenocarcinoma - blood ; Antibodies ; Antiserum ; Binding Sites, Antibody ; Binding, Competitive ; Biological Sciences: Medical Sciences ; Blood Coagulation Disorders - blood ; Blood plasma ; Coagulation ; D layer ; Epitopes ; Female ; Fibrin ; Fibrinogen ; Fibrinolysin ; Fibrinolysis ; Fibrinolytics ; Humans ; Immune Sera ; Iodine Isotopes ; Male ; Melanoma - blood ; Meningococcal Infections - blood ; Molecules ; Peritonitis - blood ; Plows ; Pregnancy ; Prostatic Neoplasms - blood ; Radioimmunoassay ; Structure-Activity Relationship ; Teeth</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1973-04, Vol.70 (4), p.1169-1173</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-e4072c1313faee23a412799905f8599335e8574ff461f2007c68c52706cc61233</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/70/4.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/62448$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/62448$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792,58237,58470</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4123931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Plow, Edward F.</creatorcontrib><creatorcontrib>Edgington, Thomas S.</creatorcontrib><title>Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Discrimination between the physiological cleavage fragments of fibrinogen and fibrin offers an approach to differentiation between fibrinogenolytic processes and fibrinolysis after coagulation. By use of the cleavage-associated neoantigen of fibrinogen (fg-Dneo) as a molecular marker, characteristic differences between the D regions of fibrinogen derivatives and fibrin derivatives can be demonstrated. The expression of fg-Dneoby X, Y, D:E complex, and D-fragments of fibrinogen or fibrin is shown to be quantitative and unitary. Characteristic differences between fg-Dneosites present on fibrinogen cleavage fragments, as contrasted to fibrin cleavage fragments, are indicated by different competitive inhibition slopes, and appear to reflect differential binding affinity of selected anti-fg-Dneoantibodies for the specific molecular site. There is a linear relationship between the slope of quantitative competitive inhibition and the relative molar ratio of fibrinogen and fibrin derivatives. Identical immunochemical expressions are observed in vitro and in vivo, and support the thesis that cleavage in vivo is produced by plasmin. The differential immunochemical features of fg-Dneoexpression may be the result of stable conformational and/or subtle structural differences between the D region of fibrinogen and fibrin cleavage fragments and suggest that precise changes in the D region are associated with the fibrin transition. These molecular features not only provide additional insight into the molecular immunology and structure of fibrinogen, but also appear to offer a new molecular approach to discrimination between fibrinogenolytic mechanisms as contrasted to fibrinolysis secondary to coagulation.</description><subject>Abruptio Placentae - blood</subject><subject>Acute Kidney Injury - blood</subject><subject>Adenocarcinoma - blood</subject><subject>Antibodies</subject><subject>Antiserum</subject><subject>Binding Sites, Antibody</subject><subject>Binding, Competitive</subject><subject>Biological Sciences: Medical Sciences</subject><subject>Blood Coagulation Disorders - blood</subject><subject>Blood plasma</subject><subject>Coagulation</subject><subject>D layer</subject><subject>Epitopes</subject><subject>Female</subject><subject>Fibrin</subject><subject>Fibrinogen</subject><subject>Fibrinolysin</subject><subject>Fibrinolysis</subject><subject>Fibrinolytics</subject><subject>Humans</subject><subject>Immune Sera</subject><subject>Iodine Isotopes</subject><subject>Male</subject><subject>Melanoma - blood</subject><subject>Meningococcal Infections - blood</subject><subject>Molecules</subject><subject>Peritonitis - blood</subject><subject>Plows</subject><subject>Pregnancy</subject><subject>Prostatic Neoplasms - blood</subject><subject>Radioimmunoassay</subject><subject>Structure-Activity Relationship</subject><subject>Teeth</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1973</creationdate><recordtype>article</recordtype><recordid>eNp9kc1vEzEQxS0EKqFw5YCEtKfedjtef60PHFBDAakCIcHZctxxcLXxBttJ6X-Po4QovfRkWe_3xs_zCHlLoaOg2OU62twp6HhHqdTPyIyCpq3kGp6TGUCv2oH3_CV5lfMdAGgxwBk547RnmtEZ-TEP2aWwCtGWEJfNN5xsLGGJMbhmHrzHhNFhbhZY7hFjcx0WKcSpAo2Nt4drM8cUtnXCFvNr8sLbMeObw3lOfl1_-nn1pb35_vnr1ceb1nEhS4scVO8oo8xbxJ7ZGklprUH4QWjNmMBBKO49l9T3AMrJwYlegXRO1vTsnHzYz11vFiu8dRhLsqNZ18_Y9GAmG8xjJYbfZjltDWeMC6j-i4M_TX82mItZ1VXgONqI0yabgWopBqUq2O1Bl6acE_rjGxTMrgOz68AoMNzsOqiG96fJjvhh6Sf6zvdfPfVfPKUbvxnHgn9LBd_twbtcpnQkZc_5wP4BE8Cj2A</recordid><startdate>19730401</startdate><enddate>19730401</enddate><creator>Plow, Edward F.</creator><creator>Edgington, Thomas S.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19730401</creationdate><title>Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives</title><author>Plow, Edward F. ; Edgington, Thomas S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-e4072c1313faee23a412799905f8599335e8574ff461f2007c68c52706cc61233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1973</creationdate><topic>Abruptio Placentae - blood</topic><topic>Acute Kidney Injury - blood</topic><topic>Adenocarcinoma - blood</topic><topic>Antibodies</topic><topic>Antiserum</topic><topic>Binding Sites, Antibody</topic><topic>Binding, Competitive</topic><topic>Biological Sciences: Medical Sciences</topic><topic>Blood Coagulation Disorders - blood</topic><topic>Blood plasma</topic><topic>Coagulation</topic><topic>D layer</topic><topic>Epitopes</topic><topic>Female</topic><topic>Fibrin</topic><topic>Fibrinogen</topic><topic>Fibrinolysin</topic><topic>Fibrinolysis</topic><topic>Fibrinolytics</topic><topic>Humans</topic><topic>Immune Sera</topic><topic>Iodine Isotopes</topic><topic>Male</topic><topic>Melanoma - blood</topic><topic>Meningococcal Infections - blood</topic><topic>Molecules</topic><topic>Peritonitis - blood</topic><topic>Plows</topic><topic>Pregnancy</topic><topic>Prostatic Neoplasms - blood</topic><topic>Radioimmunoassay</topic><topic>Structure-Activity Relationship</topic><topic>Teeth</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Plow, Edward F.</creatorcontrib><creatorcontrib>Edgington, Thomas S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Plow, Edward F.</au><au>Edgington, Thomas S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1973-04-01</date><risdate>1973</risdate><volume>70</volume><issue>4</issue><spage>1169</spage><epage>1173</epage><pages>1169-1173</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Discrimination between the physiological cleavage fragments of fibrinogen and fibrin offers an approach to differentiation between fibrinogenolytic processes and fibrinolysis after coagulation. By use of the cleavage-associated neoantigen of fibrinogen (fg-Dneo) as a molecular marker, characteristic differences between the D regions of fibrinogen derivatives and fibrin derivatives can be demonstrated. The expression of fg-Dneoby X, Y, D:E complex, and D-fragments of fibrinogen or fibrin is shown to be quantitative and unitary. Characteristic differences between fg-Dneosites present on fibrinogen cleavage fragments, as contrasted to fibrin cleavage fragments, are indicated by different competitive inhibition slopes, and appear to reflect differential binding affinity of selected anti-fg-Dneoantibodies for the specific molecular site. There is a linear relationship between the slope of quantitative competitive inhibition and the relative molar ratio of fibrinogen and fibrin derivatives. Identical immunochemical expressions are observed in vitro and in vivo, and support the thesis that cleavage in vivo is produced by plasmin. The differential immunochemical features of fg-Dneoexpression may be the result of stable conformational and/or subtle structural differences between the D region of fibrinogen and fibrin cleavage fragments and suggest that precise changes in the D region are associated with the fibrin transition. These molecular features not only provide additional insight into the molecular immunology and structure of fibrinogen, but also appear to offer a new molecular approach to discrimination between fibrinogenolytic mechanisms as contrasted to fibrinolysis secondary to coagulation.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>4123931</pmid><doi>10.1073/pnas.70.4.1169</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1973-04, Vol.70 (4), p.1169-1173
issn 0027-8424
1091-6490
language eng
recordid cdi_crossref_primary_10_1073_pnas_70_4_1169
source PubMed Central; JSTOR
subjects Abruptio Placentae - blood
Acute Kidney Injury - blood
Adenocarcinoma - blood
Antibodies
Antiserum
Binding Sites, Antibody
Binding, Competitive
Biological Sciences: Medical Sciences
Blood Coagulation Disorders - blood
Blood plasma
Coagulation
D layer
Epitopes
Female
Fibrin
Fibrinogen
Fibrinolysin
Fibrinolysis
Fibrinolytics
Humans
Immune Sera
Iodine Isotopes
Male
Melanoma - blood
Meningococcal Infections - blood
Molecules
Peritonitis - blood
Plows
Pregnancy
Prostatic Neoplasms - blood
Radioimmunoassay
Structure-Activity Relationship
Teeth
title Discriminating Neoantigenic Differences between Fibrinogen and Fibrin Derivatives
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A54%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discriminating%20Neoantigenic%20Differences%20between%20Fibrinogen%20and%20Fibrin%20Derivatives&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Plow,%20Edward%20F.&rft.date=1973-04-01&rft.volume=70&rft.issue=4&rft.spage=1169&rft.epage=1173&rft.pages=1169-1173&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.70.4.1169&rft_dat=%3Cjstor_cross%3E62448%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c456t-e4072c1313faee23a412799905f8599335e8574ff461f2007c68c52706cc61233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=81965877&rft_id=info:pmid/4123931&rft_jstor_id=62448&rfr_iscdi=true